Agrawal S, Umapathy S, Dhiman RK (2015) Minimal hepatic Encephalopathy impairs Quality of Life. J Clin Experimental Hepatol 5S42–S48. https://doi.org/10.1016/j.jceh.2014.11.006

Aldridge DR, Tranah EJ, Shawcross DL (2015) Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol 5:S7–S20. https://doi.org/10.1016/j.jceh.2014.06.004

Article  PubMed  Google Scholar 

Ampuero J, Montoliú C, Simón-Talero M, Aguilera V, Millán R, Márquez C, Jover R, Rico MC, Sendra C, Serra MÁ, Romero-Gómez M (2018) Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. J Gastroenterol Hepatol 33:718–725. https://doi.org/10.1111/jgh.13917

Article  PubMed  Google Scholar 

Arroyo V, Angeli P, Moreau R, Jalan R, Clària J, Trebicka J, Fernández J, Gustot T, Caraceni P, Bernardi M (2021) The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol 74:670–685. https://doi.org/10.1016/j.jhep.2020.11.048

Article  PubMed  CAS  Google Scholar 

Berlioux P, Robic MA, Poirson H, Métivier S, Otal P, Barret C, Lopez F, Péron JM, Vinel JP, Bureau C (2014) Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post‐TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology (Baltimore MD) 59:622–629. https://doi.org/10.1002/hep.26684

Article  PubMed  Google Scholar 

Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, Pasquale C, Nardelli S, Pentassuglio I, Merkel C, Angeli P, Riggio O, Amodio P (2017) The animal naming test: an easy tool for the assessment of hepatic encephalopathy. Hepatology 66:198–208. https://doi.org/10.1002/hep.29146

Article  PubMed  Google Scholar 

Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T (2021) Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol 74:819–828. https://doi.org/10.1016/j.jhep.2020.10.004

Article  PubMed  CAS  Google Scholar 

D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231. https://doi.org/10.1016/j.jhep.2005.10.013

Article  PubMed  Google Scholar 

D’Amico G, Morabito A, D’Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG (2018) Clinical states of cirrhosis and competing risks. J Hepatol 68:563–576. https://doi.org/10.1016/j.jhep.2017.10.020

Article  PubMed  Google Scholar 

de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C (2022) Baveno VII - renewing consensus in portal hypertension: personalized care for portal hypertension. J Hepatol 30:21–29. https://doi.org/10.3760/cma.j.cn501113-20220109-00010

Article  Google Scholar 

de Vires HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J (1996) The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. https://doi.org/10.1016/0165-5728(95)00148-4

Article  Google Scholar 

Dharel N, Bajaj JS (2015) Definition and nomenclature of hepatic Encephalopathy. J Clin Experimental Hepatol 5:S37–S41. https://doi.org/10.1016/j.jceh.2014.10.001

Article  Google Scholar 

Ehrenbauer AF, Schneider H, Stockhoff L, Tiede A, Lorenz C, Dirks M, Witt J, Gabriel MM, Wedemeyer H, Hinrichs JB, Weissenborn K, Maasoumy B (2023) Predicting overt hepatic encephalopathy after TIPS: value of three minimal hepatic encephalopathy tests. JHEP Rep 5:100829. https://doi.org/10.1016/j.jhepr.2023.100829

Article  PubMed  PubMed Central  Google Scholar 

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M (2021) Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol 75:S49–S66. https://doi.org/10.1016/j.jhep.2021.01.002

Article  PubMed  PubMed Central  CAS  Google Scholar 

European Association for the Study of the Liver (2018) EASL Clinical Practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 69:406–460. https://doi.org/10.1016/j.jhep.2018.03.024

Article  Google Scholar 

European Association for the Study of the Liver (2022) EASL Clinical Practice guidelines on the management of hepatic encephalopathy. J Hepatol 77:807–824. https://doi.org/10.1016/j.jhep.2022.06.001

Article  Google Scholar 

Flud CR, Duarte-Rojo A (2019) Prognostic implications of Minimal/Covert hepatic encephalopathy: large-scale validation cohort studies. J Clin Exp Hepatol 9:112–116. https://doi.org/10.1016/j.jceh.2018.04.009

Article  PubMed  Google Scholar 

Gairing SJ, Anders J, Kaps L, Nagel M, Michel M, Kremer WM, Hilscher M, Galle PR, Schattenberg JM, Wörns M, Labenz C (2022a) Evaluation of IL-6 for stepwise diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Commun 6:1113–1122. https://doi.org/10.1002/hep4.1883

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gairing SJ, Müller L, Kloeckner R, Galle PR, Labenz C (2022b) Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectives. Aliment Pharmacol Ther 55:1265–1276. https://doi.org/10.1111/apt.16825

Article  PubMed  Google Scholar 

García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G (2020) Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2:100122. https://doi.org/10.1016/j.jhepr.2020.100122

Article  PubMed  PubMed Central  Google Scholar 

Labenz C, Schattenberg JM (2018) Animal naming test - animals as diagnostic solution? Z Gastroenterol 56:168–169. https://doi.org/10.1055/s-0043-117268

Article  PubMed  Google Scholar 

Labenz C, Toenges G, Huber Y, Nagel M, Marquardt JU, Schattenberg JM, Galle PR, Labenz J, Wörns M (2019) Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Aliment Pharmacol Ther 50:1112–1119. https://doi.org/10.1111/apt.15515

Article  PubMed  CAS  Google Scholar 

Larrue H, D’Amico G, Olivas P, Lv Y, Bucsics T, Rudler M, Sauerbruch T, Hernandez-Gea V, Han G, Reiberger T, Thabut D, Vinel J, Péron J, García-Pagán J, Bureau C (2023) TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis. J Hepatol 79:692–703. https://doi.org/10.1016/j.jhep.2023.04.028

Article  PubMed  Google Scholar 

Lehmann JM, Claus K, Jansen C, Pohlmann A, Schierwagen R, Meyer C, Thomas D, Manekeller S, Claria J, Strassburg CP, Trautwein C, Wasmuth HE, Berres M, Trebicka J (2018) Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality. Liver Int 38:875–884. https://doi.org/10.1111/liv.13610

Article  PubMed  CAS  Google Scholar 

Li J, Liu Y, Li M, Rong X, Yuan Z, Ren C, Liu S, Li L, Zhao C, Gao L, Feng D (2023) Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS. Hepatol Commun 7. https://doi.org/10.1097/HC9.0000000000000128

Marquardt S, Rodt T, Rosenthal H, Wacker F, Meyer BC (2015) Impact of anatomical, procedural, and Operator Skill factors on the success and duration of Fluoroscopy-guided Transjugular Intrahepatic Portosystemic Shunt. Cardiovasc Intervent Radiol 38:903–912. https://doi.org/10.1007/s00270-014-1035-6

Article  PubMed  Google Scholar 

Meine TC, Dewald CLA, Becker LS, Mähringer-Kunz A, Maasoumy B, Maschke SK, Kirstein MM, Werncke T, Wacker FK, Meyer BC, Hinrichs JB (2020) Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy. Abdom Radiol 45:3934–3943. https://doi.org/10.1007/s00261-020-02589-1

Article  Google Scholar 

Nardelli S, Gioia S, Pasquale C, Pentassuglio I, Farcomeni A, Merli M, Salvatori FM, Nikolli L, Torrisi S, Greco F, Nicoletti V, Riggio O (2016) Cognitive impairment predicts the occurrence of hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol 111:523–528. https://doi.org/10.1038/ajg.2016.29

Article  PubMed  Google Scholar 

Nardelli S, Riggio O, Marra F, Gioia S, Saltini D, Bellafante D, Adotti V, Guasconi T, Ridola L, Rosi M, Caporali C, Fanelli F, Roccarina D, Bianchini M, Indulti F, Spagnoli A, Merli M, Vizzutti F, Schepis F (2024) Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis. J Hepatol 80:596–602. https://doi.org/10.1016/j.jhep.2023.11.033

Article  PubMed  Google Scholar 

Pereira K, Carrion AF, Salsamendi J, Doshi M, Baker R, Kably I (2016) Endovascular management of refractory hepatic Encephalopathy complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm. Cardiovasc Intervent Radiol 39:170–182. https://doi.org/10.1007/s00270-015-1197-x

Article  PubMed  Google Scholar 

Praktiknjo M, Simón-Talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-González J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R et al (2020) Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. J Hepatol 72:1140–1150. https://doi.org/10.1016/j.jhep.2019.12.021

Ar